Elucid Bioimaging

Elucid Bioimaging, Inc. (operating as Elucid) is a Boston, Massachusetts medical technology company building AI-based image analysis software for cardiovascular disease. Its flagship product, Plaque-IQ, is an FDA-cleared CT-based plaque analysis platform indicated for both coronary and carotid anatomies: it applies image-restoration and segmentation algorithms to coronary CT angiography (CCTA) studies to quantify and classify lesion-level plaque morphology — including lipid-rich necrotic core — producing CAD-RADS classifications, straightened multi-planar reconstructions and a physician-validated PDF report. Elucid also offers an FFR-CT capability. The company sells to health systems, cardiologists, radiologists and vascular specialists through a clinical sales motion, and its go-to-market runs on reimbursement (Medicare Administrative Contractor, United Healthcare and EviCore coverage) rather than self-service signup. Elucid publishes no public developer program, API reference, SDK or machine-readable specification; the product is delivered as an end-user clinical platform.

Elucid Bioimaging is profiled on the APIs.io network. Tagged areas include Company, Health, Medical Imaging, Artificial Intelligence, and Cardiovascular.

Elucid Bioimaging’s developer surface includes engineering blog, YouTube channel, and 12 more developer resources.

8.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyHealthMedical ImagingArtificial IntelligenceCardiovascularRadiologyDiagnosticsMedical Devices

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 8.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/elucid-bioimaging: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Pricing Plans 1

Published pricing tiers and plan structures.

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Elucid Bioimaging Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Learn 1

Tutorials, courses, talks, and written guidance

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 6

The organization behind the API

Other 3

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: elucid-bioimaging
name: Elucid Bioimaging
description: 'Elucid Bioimaging, Inc. (operating as Elucid) is a Boston, Massachusetts medical technology company building
  AI-based image analysis software for cardiovascular disease. Its flagship product, Plaque-IQ, is an FDA-cleared CT-based
  plaque analysis platform indicated for both coronary and carotid anatomies: it applies image-restoration and segmentation
  algorithms to coronary CT angiography (CCTA) studies to quantify and classify lesion-level plaque morphology — including
  lipid-rich necrotic core — producing CAD-RADS classifications, straightened multi-planar reconstructions and a physician-validated
  PDF report. Elucid also offers an FFR-CT capability. The company sells to health systems, cardiologists, radiologists and
  vascular specialists through a clinical sales motion, and its go-to-market runs on reimbursement (Medicare Administrative
  Contractor, United Healthcare and EviCore coverage) rather than self-service signup. Elucid publishes no public developer
  program, API reference, SDK or machine-readable specification; the product is delivered as an end-user clinical platform.'
url: https://raw.githubusercontent.com/api-evangelist/elucid-bioimaging/refs/heads/main/apis.yml
image: https://elucid.com/wp-content/uploads/2025/10/elucid-logo.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Health
- Medical Imaging
- Artificial Intelligence
- Cardiovascular
- Radiology
- Diagnostics
- Medical Devices
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://elucid.com/
- type: Company
  url: https://elucid.com/about-elucid/
- type: Contact
  url: https://elucid.com/contact/
- type: Careers
  url: https://elucid.com/careers-at-elucid/
- type: Blog
  url: https://elucid.com/about-elucid/#news
- type: BlogRSS
  url: https://elucid.com/feed/
- type: PrivacyPolicy
  url: https://elucid.com/privacy-policy/
- type: CookiePolicy
  url: https://elucid.com/cookie-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/elucid-inc/
- type: YouTube
  url: https://www.youtube.com/@elucidbioimaging
- type: Twitter
  url: https://x.com/ElucidBio
- type: LLMsTxt
  url: llms/elucid-bioimaging-llms.txt
- type: DomainSecurity
  url: security/elucid-bioimaging-domain-security.yml
- type: SecondaryMarket
  url: https://forgeglobal.com/elucid-bioimaging_stock/
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 4
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Elucid ships Plaque-IQ as an FDA-cleared end-user clinical imaging application sold to health systems, and publishes
    no developer surface at all — elucid.com/api/, /developers/, /docs and /openapi.json all 404, and no api./docs./developer./app.
    subdomain even resolves in DNS.
  evidence:
  - url: https://elucid.com/developers/
    status: 404
  - url: https://elucid.com/api/
    status: 404
  - url: https://elucid.com/openapi.json
    status: 404
  - url: https://elucid.com/.well-known/agent-card.json
    status: 404
  - url: https://elucid.com/llms.txt
    status: 200
  checked: '2026-08-12'